Literature DB >> 22119733

Chitosan enhances transcellular permeability in human and rat intestine epithelium.

M Magdalena Canali1, Luciano P Pedrotti, Jesús Balsinde, Cristina Ibarra, Silvia G Correa.   

Abstract

The intestinal epithelium regulates the transit of molecules from and into the organism. Several agents act as absorption enhancers inducing changes in both transcellular and paracellular routes. Chitosan is a non-toxic biocompatible polysaccharide widely used as dietary supplement and mucosal delivery. Chitosan triggers both the activation of intestinal epithelial cells and the release of regulatory factors relevant for its immunomodulatory activity. Yet, the interaction of chitosan with intestinal epithelial cells is poorly characterized. We studied the uptake of this polysaccharide, and we evaluated its effects in both the net water and ion movements across human and rat colon samples and the epithelial permeability. Herein, we demonstrate that chitosan increases the transcellular permeability to ions, water and protein markers in human and rat intestinal mucosa and decreases the water permeability across the paracellular pathway. These findings are relevant to understand the activity of the polysaccharide in the mucosal environment.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22119733     DOI: 10.1016/j.ejpb.2011.11.007

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  6 in total

1.  The complete functional recovery of chitosan-treated biomimetic hyperplastic and normoplastic urothelial models.

Authors:  Tanja Višnjar; Mateja Erdani Kreft
Journal:  Histochem Cell Biol       Date:  2014-08-27       Impact factor: 4.304

2.  Chitosan oligosaccharides alleviate PM2.5-induced lung inflammation in rats.

Authors:  Yingzheng Zhao; Guangcui Xu; Shouying Wang; Xianwen Yi; Weidong Wu
Journal:  Environ Sci Pollut Res Int       Date:  2018-10-05       Impact factor: 4.223

3.  In vivo dual-delivery of glucagon like peptide-1 (GLP-1) and dipeptidyl peptidase-4 (DPP4) inhibitor through composites prepared by microfluidics for diabetes therapy.

Authors:  F Araújo; N Shrestha; M J Gomes; B Herranz-Blanco; D Liu; J J Hirvonen; P L Granja; H A Santos; B Sarmento
Journal:  Nanoscale       Date:  2016-05-19       Impact factor: 7.790

4.  Surface-modified mucoadhesive microparticles as a controlled release system for oral delivery of insulin.

Authors:  Momoh A Mumuni; Frankilin C Kenechukwu; Omeje C Ernest; Adedokun M Oluseun; Barikisu Abdulmumin; Darlington C Youngson; Ofokansi C Kenneth; Attama A Anthony
Journal:  Heliyon       Date:  2019-09-12

5.  The Barrier-Enhancing Function of Soluble Yam (Dioscorea opposita Thunb.) Polysaccharides in Rat Intestinal Epithelial Cells as Affected by the Covalent Se Conjugation.

Authors:  Zhen-Xing Wang; Xin-Huai Zhao
Journal:  Nutrients       Date:  2022-09-23       Impact factor: 6.706

6.  Complex Polysaccharide-Based Nanocomposites for Oral Insulin Delivery.

Authors:  Mar Collado-González; M Cristina Ferreri; Alessandra R Freitas; Ana Cláudia Santos; Nuno R Ferreira; Guzmán Carissimi; Joana A D Sequeira; F Guillermo Díaz Baños; Gloria Villora; Francisco Veiga; Antonio Ribeiro
Journal:  Mar Drugs       Date:  2020-01-15       Impact factor: 5.118

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.